180 |
The Continuation of Erlotinib Treatment in Non-Small Cell Lung Cancer Patients Whose Brain Lesion Is the Only Site of Progression: Prospective Pilot StudyThe Continuation of Erlotinib Treatment in Non-Small Cell Lung Cancer Patients Whose Brain Lesion Is the Only Site of Progression: Prospective Pilot Study
Kwai Han Yoo, Seung Tae Kim, Ki Sun Jung, Ji Yun Lee, Sung Hee Lim, Min-Young Lee, Hae Soo Kim, Hee Jin Kwon, In Young Kim, Jong-Mu Sun, Jin Seok Ahn, Keunchil Park, Myung-Ju AhnKwai Han Yoo, Seung Tae Kim, Ki Sun Jung, Ji Yun Lee, Sung Hee Lim, Min-Young Lee, Hae Soo Kim, Hee Jin Kwon, In Young Kim, Jong-Mu Sun, Jin Seok Ahn, Keunchil Park, Myung-Ju Ahn
KMSID: 1044234 Hanyang Med Rev. 2015;35(3):180-185. Published online 2015 August 20 DOI: http://dx.doi.org/10.7599/hmr.2015.35.3.180 |